1. Home
  2. GPRO vs ALLO Comparison

GPRO vs ALLO Comparison

Compare GPRO & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPRO
  • ALLO
  • Stock Information
  • Founded
  • GPRO 2004
  • ALLO 2017
  • Country
  • GPRO United States
  • ALLO United States
  • Employees
  • GPRO N/A
  • ALLO N/A
  • Industry
  • GPRO Industrial Machinery/Components
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GPRO Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • GPRO Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • GPRO 194.6M
  • ALLO 231.9M
  • IPO Year
  • GPRO 2014
  • ALLO 2018
  • Fundamental
  • Price
  • GPRO $1.49
  • ALLO $1.15
  • Analyst Decision
  • GPRO
  • ALLO Strong Buy
  • Analyst Count
  • GPRO 0
  • ALLO 10
  • Target Price
  • GPRO N/A
  • ALLO $8.88
  • AVG Volume (30 Days)
  • GPRO 9.1M
  • ALLO 4.0M
  • Earning Date
  • GPRO 08-11-2025
  • ALLO 08-13-2025
  • Dividend Yield
  • GPRO N/A
  • ALLO N/A
  • EPS Growth
  • GPRO N/A
  • ALLO N/A
  • EPS
  • GPRO N/A
  • ALLO N/A
  • Revenue
  • GPRO $746,731,000.00
  • ALLO N/A
  • Revenue This Year
  • GPRO N/A
  • ALLO N/A
  • Revenue Next Year
  • GPRO $9.72
  • ALLO $100.00
  • P/E Ratio
  • GPRO N/A
  • ALLO N/A
  • Revenue Growth
  • GPRO N/A
  • ALLO N/A
  • 52 Week Low
  • GPRO $0.40
  • ALLO $0.86
  • 52 Week High
  • GPRO $2.37
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • GPRO 55.12
  • ALLO 50.12
  • Support Level
  • GPRO $1.43
  • ALLO $1.06
  • Resistance Level
  • GPRO $1.58
  • ALLO $1.21
  • Average True Range (ATR)
  • GPRO 0.15
  • ALLO 0.08
  • MACD
  • GPRO -0.01
  • ALLO 0.01
  • Stochastic Oscillator
  • GPRO 44.29
  • ALLO 50.00

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: